Cytotrait, aspinout from The University of Manchester focused on developing new traits forfood and agricultural applications, has closed a £3 million seed funding round.The round was led by Northern G…
University of Edinburgh spin-out BIOCAPTIVA has raised £1.58 million in a new funding round and launched its first product in the US. BIOCAPTIVA’s novel magnetic bead technology is designed to solve o…
Wilbe, the venture fund and platform that trains and backs scientists to build companies from day one, today announces the launch of its first dedicated lab facility in White City, London.To date, Wil…
London-basedbiomaterials company Shellworks has raised $15 million in a Series A fundinground led by Paris-based impact investment fund alter equity. The round alsoincluded participation from Nat Frie…
UK-based Antiverse, abiotech company developing AI-designed therapeutic antibodies forhard-to-target disease targets, has closed a $9.3 million Series A round led bySoulmates Ventures, with participat…
Outpost Bio, a companyfocused on decoding complex interactions in human biology, has raised a $3.5million pre-seed round co-led by Merantix Capital and Seedcamp, withparticipation from OpenSeed VC, De…
Behind every brightly coloured garment lies a largely invisible cost. Dyeing synthetic fibres can account for up to 60 per cent of the total energy used in textile production, while the global dyeing …
Dutch-basedstartup QT Sense has raised €4 million to advance Quantum Nuova, aquantum-based platform that monitors cellular stress in living cells atsingle-cell resolution. The funding includes a €3 mi…
Munich-based Twogee Biotech, a biotechnology start-up developing customised enzyme solutions forthe industrial conversion of biomass into sustainable raw materials, hascompleted a €2.16 million seed f…
When Elon Musk was at Davos last week, an interviewer asked him if he thought aging could be reversed. Musk said he hasn’t put much time into the problem but suspects it is “very solvable” and that when scientists discover why we age, it’s going to be something “obvious.” Not long after, the Harvard professor…